baber/WOPTO huggingface dataset:
Patent NZ-575091-A (NZ)
Title: Reusable inversion sleeve assembly for inversion of cured in place liners
Inventor: DRIVER FRANKLIN THOMAS
IPC: F16L55/165
Filed: 2007-08-29
Abstract: An inversion sleeve assembly for installation of a cured in place pipe liner (200) is disclosed. The assembly comprises a flexible tubular sleeve (207), a substantially rigid banding boot (211) with a second fluid inlet port formed in the sidewall. The flexible tubular sleeve (207) has proximal and distal ends and includes a first fluid inlet port installed in a side of the flexible sleeve between the proximal and distal ends. The distal end of the flexible sleeve secured to the proximal end of the banding boot.
Patent NZ-576682-A (NZ)
Title: METHOD OF DRUG DELIVERY FOR BONE ANABOLIC PROTEIN PARATHYROID HORMONE-RELATED PROTEIN (PTHrP)
Inventor: DEY MICHAEL J
IPC: A61K9/08
Filed: 2007-10-03
Abstract: A storage-stable composition that is suitable for administration and comprises: a) a PTHrP analogue having the sequence [Glu22,25, Leu23,28,31, Aib29, Lys26,30]hPTHrP(1-34)NH2 (SEQ IDNO:2); and b) an effective amount of a pH buffer to maintain the pH in a range of 4.5 to 5.6. The composition can be used to improve bone mass, stimulating bone growth and in the treatment of osteoporosis.
Patent NZ-582420-A (NZ)
Title: Novel crystals and process of making 5-({ [2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1h-imidazol-2-yl)-ethyl]-amino} -methyl)-2-methoxy- benzoic acid
Inventor: ANZALONE LUIGI
IPC: A61K31/4164
Filed: 2008-07-07
Abstract: Disclosed is a method of preparing the zwitterion of 5-({ [2-amino-3-( 4-carbamoyl-2,6-dimethyl-phenyl)propionyl]-[1-( 4-phenyl-1h-imidazol-2-yl)-ethyl]-amino} -methyl)-2-methoxy-benzoic acid comprising the steps of combining a strong ionizable acid with 5-( { [2-tert-butoxycarbonylamino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1H-imidazol-2-yl)-ethyl]-amino} -methyl)-2-methoxybenzoic acid to prepare a salt of5-({ [2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl][1-(4-phenyl-1h-imidazol-2-yl)-ethyl]-amino} -methyl)-2-methoxy-benzoic acid; and washing said salt of 5-( { [2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1 h-imidazol-2-yl)-ethyl]-amino} -methyl)-2-methoxy-benzoic acid an inorganic base to obtain the zwitterion of 5-({ [2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1 h-imidazol-2-yl)-ethyl]-amino} -methyl)-2-methoxy-benzoic acid. Also disclosed is the 5-({ [2-amino-3-( 4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-( 4- phenyl-1h-imidazol-2-yl)-ethyl]-amino} -methyl)-2-methoxy-benzoic acid prepared from the method for treating irritable bowel syndrome, pain or another opioid receptor disorder.
Patent NZ-582947-A (NZ)
Title: Associative thickener dispersion
Inventor: LEYRER REINHOLD
IPC: C08F220/10
Filed: 2008-08-01
Abstract: Disclosed herein is an associative thickener comprising an aqueous dispersion of an alkali-soluble copolymer with copolymerized units a) of at least one ethlenically unsaturated carboxylic acid, b) of at least one non-ionic ethylenically unsaturated surfactant monomer, c) of at least one C1-C2-alkyl methacrylate, d) of at least one C2-C4-alkyle acrylate, where the alkyl chain length averaged over the number of alkyl groups of the alkyl acrylate is 2.1 to 4.0. Also disclosed are methods for the preparation of said thickener and also liquid detergent or cleaner composition comprising said thickener composition.
Patent NZ-586411-A (NZ)
Title: Substantially animal protein-free recombinant furin and methods for producing same
Inventor: VON FIRCKS SIMONE
IPC: C07K14/755
Filed: 2008-12-19
Abstract: Disclosed is a position comprising substantially animal protein-free recombinant furin. Further disclosed is an ex vivo method of making substantially animal protein-free recombinant furin comprising the step of growing a host cell transformed or transfected with a polynucleotide encoding furin in serum-free medium under conditions that permit secretion of the furin into the medium.
Patent NZ-590509-A (NZ)
Title: Apparatus for processing of plant material with a toothed roller with the leading portion of the teeth shorter than the trailing portion
Inventor: CLARKE ADRIAN FRANCIS K
IPC: D01B1/28
Filed: 2006-03-09
Abstract: An apparatus for processing at least one plant stalk having a fibrous outer part (skin) and an inner section (hurd) comprises a toothed roller 10 and a bending element, where the toothed roller 10 comprises teeth 13 projecting from the surface of the roller 10. Each tooth comprises a leading portion 22 and a trailing portion 23 where the leading portion 22 extends a shorter radial distance from the roller 10 compared to the trailing portion 23. The plane XX of the teeth 13 when horizontally aligned defines a scissor plane XX and the bending element is positioned below the scissor plane XX, such that on contact of the stalks with the bending element and the teeth 13, the stalks are caused to bend, the fibrous outer part is caused to split and the inner hurd is substantially separated from the fibrous outer part.
Patent NZ-591231-A (NZ)
Title: Production of canola protein isolate without heat treatment
Inventor: SEGALL KEVIN I
IPC: A23J1/14
Filed: 2009-08-18
Abstract: Disclosed herein is a process of preparing a canola protein isolate having a protein content of at least 90 wt% (N x 6.25) on a dry weight basis, which includes: (a). optionally (i) partially concentrating the supernatant from the precipitation of a canola protein micellar mass to a concentration of 50 g/L or less, or (ii) concentrating the supernatant from the precipitation of a canola protein micellar mass to a concentration of at least 50 g/L; (b). adding a calcium salt (i) to supernatant from the precipitation of canola protein micellar mass in the absence of optional step (a) to provide a conductivity of 5 to 30 mS to form a calcium phytate precipitate, or (ii) to the partially concentrated supernatant or concentrated supernatant in the presence of optional step (a) to provide a conductivity of 2 to 30 mS to form a calcium phytate precipitate, (iii) removing precipitated calcium phytate from the resulting solution to provide a clear solution, (iv) optionally adjusting the pH of the clear solution to 2.0 to 4.0 to form a pH-adjusted clear solution, and (v) in the absence of optional step (aii) or in the presence of step (ai), concentrating the optionally pH-adjusted clear solution to a concentration of at least 50 g/L to form a clear concentrated canola protein solution, or (bII). (i) adding an initial amount of calcium salt to supernatant from the precipitation of canola protein micellar mass to provide a conductivity of 1 to 3.5 mS and insufficient to cause precipitation of calcium phytate, (ii) adjusting the pH of the resulting solution to 2.0 to 4.0 to form an acidified solution, (iii) partially concentrating the acidified solution to a concentration of 50 g/L or less, (iv) adding a further quantity of a calcium salt to the partially concentrated solution to provide a conductivity of 4 to 30 mS and to cause a precipitate to form, (v) removing the precipitate from the resulting solution to provide a clear pH- adjusted solution, and (vi) concentrating the clear pH-adjusted solution to a concentration of at least 50 g/L to produce a concentrated canola protein isolate; (c). optionally diafiltering the clear concentrated canola protein solution, (d). optionally effecting a colour removal step on the optionally diafiltrated clear concentrated canola protein solution, and (e). drying the optionally discoloured and optionally diafiltered clear concentrated protein solution.
Patent NZ-592095-A (NZ)
Title: Isolation and purification of il-12 and tnf-alpha antibodies using protein a affinity chromatography
Inventor: HICKMAN ROBERT K
IPC: C07K16/24
Filed: 2009-10-20
Abstract: Disclosed is a method for producing a host cell protein (HCP) reduced antibody, or antigen binding portion thereof, preparation from a sample mixture comprising an antibody, or antigen binding portion thereof, and at least one HCP, said method comprising: Subjecting said sample mixture to a reduction in pH thus forming a primary recovery sample, wherein said reduction in pH is from about 3 to about 4; Adjusting said primary recovery sample to a pH of about 6.0 to about 8 followed by; Contacting said primary recovery sample to a Protein A affinity chromatography resin, washing said affinity chromatography resin with a buffer selected from the group consisting of: (i) a buffer comprising 0.5 M NaCl, 25mM sodium acetate, at pH 5; (ii) a buffer comprising 0.5 M NaCl, 25 mM sodium acetate, at pH 5.5 and (iii) a buffer comprising 0.5 M NaCl, 20 mM citric acid/Na citrate, at pH 6, and collecting an affinity chromatography sample; Contacting said affinity chromatography sample to an ion exchange resin and collecting an ion exchange sample; Contacting said ion exchange sample to a hydrophobic interactive chromatography (HIC) resin and collecting an HIC sample, wherein said HIC sample comprises said HCP-reduced antibody, or antigen binding portion thereof, preparation.
Patent NZ-592119-A (NZ)
Title: Anti-pd-l1 antibodies and their use to enhance t-cell function
Inventor: IRVING BRYAN
IPC: A61K39/395
Filed: 2009-12-08
Abstract: Patent No. 592119 Disclosed is an isolated heavy chain variable region polypeptide that specifically binds to PD-L1 comprising an HVR-H1, HVR-H2 and HVR-H3 sequence, wherein: (a) the HVR-H1 sequence is GFTFSX1SWIH; (b) the HVR-H2 sequence is AWIX2PYGGSX3YYADSVK; (c) the HVR-H3 sequence is RHWPGGFDY; further wherein: X1 is D or G; X2 is S or L; X3 is T or S. Also disclosed is an isolated anti-PD-L1 antibody or antigen binding fragment, said antibody comprising a heavy chain and a light chain variable region sequence, wherein: (a) the heavy chain comprises an HVR-H1, HVR-H2 and HVR-H3, wherein further: (i) the HVR-H1 sequence is GFTFSX1SWIH; (ii) the HVR-H2 sequence is AWIX2PYGGSX3YYADSVKG; (iii) the HVR-H3 sequence is RHWPGGFDY; and (b) the light chain comprises an HVR-L1, HVR-L2 and HVR-L3, wherein further: (iv) the HVR-L1 sequence is RASQX4X5X6TX7X8A; (v) the HVR-L2 sequence is SASX9LX10S; (vi) the HVR-L3 sequence is QQX11X12X13X14PX15T; wherein: X1 is D or G; X2 is S or L; X3 is T or S; X4 may be D or V; X5 may be V or I; X6 may be S or N; X7 may be A or F; X8 may be V or L; X9 may be F or T; X10 may be Y or A; X11 may be Y, G, F, or S; X12 may be L, Y, F or W; X13 may be Y, N, A, T, G, F or I; X14 may be H, V, P, T or I; X15 may be A, W, R, P or T.
Patent NZ-596279-A (NZ)
Title: COMPOSITION AND METHOD FOR CONTROLLING PLANT DISEASES comprising 4-oxo-4-[(2-phenylethyl)amino]-butyric acid and a quinone outside inhibitor
Inventor: KURAHASHI MAKOTO
IPC: A01C1/06
Filed: 2010-05-21
Abstract: 596279 A composition for controlling plant diseases comprising, as active ingredients, 4-oxo-4-[(2-phenylethyl)amino]-butyric acid and a quinone outsideinhibitor selected from the group consisting of kresoxim-methyl, azoxystrobin, trifloxystrobin, fluoxastrobin, picoxystrobin, pyraclostrobin, dimoxystrobin, pyribencarb, metominostrobin, orysastrobin, enestrobin, and a compound of formula (1), wherein X1, X2, and X3 are defined herein. Additionally disclosed is a method for controlling plant diseases comprising applying an effective amount of said composition.
Patent NZ-601207-A (NZ)
Title: Method for producing individual compacts suitable for coke oven chambers by dividing a coal cake in a non-mechanical manner
Inventor: KIM RONALD
IPC: B23K26/40
Filed: 2010-12-14
Abstract: Method for the production of compacted individual blocks suitable for coke-oven chambers by non-mechanical cutting of a compressed coal cake. The coal is compressed and compacted into one or a plurality of coal cake portions by means of a suitable compression device to obtain at least one densely packed and lump-free coal cake. The coal cake obtained is cut into compacted blocks by non-mechanical, cutting-energy providing media. The method obtains compacted coal blocks from a compressed coal cake.
Patent NZ-603451-A (NZ)
Title: Arm exercise device and system
Inventor: KING MARCUS
IPC: A61H1/00
Filed: 2012-11-07
Abstract: Disclosed is an arm rehabilitation system for exercising a user’s arm. The system includes an arm support device (104a) moveable upon a support surface by a user’s first arm when the arm is supported by the arm support device (104a). The arm support device has a main body (104) configured to movably engage the support surface on one side and comprising a hand support portion (104b) on an opposing side at or toward one end of the body for supporting a user’s hand of the first arm. Also included is a primary hand support formation (110) protruding from the hand support portion (104b) and shaped to engage with the palm and/or fingers of the user’s hand of the first arm. An adjustable switch support boom assembly (123) is mounted to the main body and has at least one operable user input component (125) for generating an actuation signal in response to operation by the user. The switch support boom (123) assembly enables adjustment of the position of the input component (125) relative to the user’s hand and/or fingers of the first arm. The input component(s) (125) are releasably and/or moveably coupled to the boom assembly (123) such that their position along the boom assembly (123) may be altered. An on-board motion tracking system is mounted to or within the main body (104) which is configured to sense motion of the main body (104) relative to the support surface and generates a representative motion signal. An interactive computer system in included which has a processor running an application program displayed on a visual display and which is in signal communication with the arm support device (100). The computer system receives and processes the motion and/or switch signals to enable the user to interact with the application program via the arm support device (104a).
Patent NZ-607870-A (NZ)
Title: Lactococcus crispr-cas sequences
Inventor: HORVATH PHILIPPE
IPC: C12Q1/68
Filed: 2011-10-20
Abstract: Disclosed is a nucleic acid comprising a Lactococcus CRISPR repeat region and a Lactococcus cas gene, wherein: (a) the Lactococcus CRISPR repeat region is corresponding to SEQ ID No: 24, or a sequence having at least 85% identity determined over the full length sequence of SEQ ID No: 24; and (b) the Lactococcus cas gene is selected from the group consisting of SEQ ID Nos: 2, 3, 5, 7, 9, 11, 13, 15, 17, 19, and/or 21, or a sequence having at least 85% identity determined over the full length sequence of any one of SEQ ID No: 2, 3, 5, 7, 9, 11, 13, 15, 17, 19, and/or 21.
Patent NZ-618575-A (NZ)
Title: Improved honeybee repellents and uses thereof
Inventor: WOODS DANIEL
IPC: A01P17/00
Filed: 2012-05-04
Abstract: Disclosed is the use of a honeybee repellent to repel a honeybee from a location or structure by applying the honeybee repellent to the location, the structure and/or in a vicinity nearby the location or the structure, wherein the honeybee repellent has a repellent activity that substantially mimics a repellent chemosensory cue of 2-heptanone, and wherein the honeybee repellent has a half-life of at least one day. Examples of honey bee repellents are: 1-benzyl-4-(4-methoxy-2,3-dimethylbenzyl) piperazine, 1-[(6-nitro-1,3-benzodioxol-5- yl)methyl]-4-phenylpiperazine, 1-(1,3-benzodioxol-5-ylmethyl)-4-(4,5-dimethoxy-2-nitrobenzyl) piperazine and 1-(3-chlorophenyl)-4-[(6-nitro-1,3-benzodioxol-5-yl)methyl]piperazine.
Patent NZ-626541-A (NZ)
Title: Wood adhesive formulation comprising an isocyanate, a polyether and an amino resin
Inventor: HOLVOET SERVAAS
IPC: C08L97/02
Filed: 2013-01-08
Abstract: Disclosed is an adhesive formulation comprising: a first component which is formed from at least one isocyanate and at least one amino resin, wherein said amino resin is the condensation product of an aldehyde with a compound selected from the group comprising urea, melamine, benzoguanamine, glycoluril, and acetoguanamine (e.g., urea-formaldehyde).; and a second component comprising at least one polyether, wherein said polyether comprises at least one ethylene oxide moiety and at least one isocyanate reactive group selected from the group comprising hydroxyl, amino, epoxy, and thiol, preferably hydroxyl.
Patent NZ-631826-A (NZ)
Title: Improved process for purifying lactoferrin from milk and products thereof
Inventor: BROWN ANDREW
IPC: C07K14/79
Filed: 2013-10-08
Abstract: A process for purifying lactoferrin from milk the process comprises subjecting the milk to filtration with a filter of molecular weight cut off (MWCO) 30-50 kD to separate the milk into a retentate fraction comprising lactoferrin and a permeate fraction comprising growth factors and/or RNAses with a molecular weight of less than 30 kD. During filtration with the filter of MWCO 30-50 kD, the milk or retentate is subjected to salt treatment such that growth factors and/or RNAses flow into the permeate, the salt treatment comprising maintaining the milk or retentate fraction at a salt concentration of at least 0.2M NaCl or equivalent or a conductivity of at least 20 mS/cm during the filtration with the filter of MWCO 30-50 kD.
Patent NZ-705008-A (NZ)
Title: Novel modulators and methods of use
Inventor: HAMPL JOHANNES
IPC: G01N33/574
Filed: 2011-12-07
Abstract: Disclosed is the use of an anti-EFNA4 antibody or fragment thereof in the manufacture of a medicament for treating an EFNA4-associated disorder.
Patent NZ-709427-A (NZ)
Title: Balloon catheter with adjustable inner member
Inventor: STAPLETON COREY E
IPC: A61M25/10
Filed: 2013-12-31
Abstract: The present invention provides a balloon catheter having an adjustable inner member that allows the balloon to foreshorten on inflation. A balloon catheter (10) comprises a shaft (14, 24) extending in a longitudinal direction and having a proximal end and a distal end and an inflatable balloon (12) positioned along the shaft (14, 24). The balloon (12) includes a portion sealed to the shaft (14, 24) and a portion connected to the shaft (14, 24) and adapted for moving toward the proximal end when the balloon (12) is inflated. An actuator (30) is provided that connects the shaft (14, 24) to the balloon (12). Figures 6, 10 & 11
Patent NZ-716599-A (NZ)
Title: Method and apparatus for oral flow therapy
Inventor: HOLLEY LIAM
IPC: A62B9/06
Filed: 2013-04-30
Abstract: Disclosed is a CPAP therapy system configured to wash out or flush out the oral and/or nasal cavity to reduce the effective dead space and reduce the work of breathing. The system may displace the expired air in the oral and/or nasal cavity with atmospheric air, or air with altered concentrations, for example, increased humidity, or oxygen levels. A sealed oral interface is provided to the mouth of a patient to supply a volume of pressurized gas. A control system to synchronize the supply of pressurized gas with the patients respiratory cycle. The supply of respiratory gas may be provided during only a portion of the respiratory cycle.
Patent NZ-718752-A (NZ)
Title: Handling vehicle and electrolysis plant comprising said vehicle
Inventor: PRODENT STÉPHANE
IPC: F16P7/00
Filed: 2014-10-23
Abstract: The invention relates to a vehicle (1) comprising: means for approaching a load; means for remotely detecting an obstacle, capable of scanning a detection zone (8); means for collecting kinematic data, intended to collect one or more items of data relating to the kinematics of the vehicle (1); a processing unit (16) intended to define a surveillance zone inside the detection zone (8), the shape of the surveillance zone being calculated by the processing unit (16) according to the kinematic data provided by the collection means. In addition, the vehicle (1) comprises means for the contact-based detection of obstacles, arranged on a portion of the vehicle (1) intended to face the load to be to be approached during an approach manoeuvre, and braking means intended to stop the vehicle (1) as soon as an obstacle is struck by the contact-based obstacle detection means.
Patent NZ-729426-A (NZ)
Title: Furniture member and power recline and lift mechanism
Inventor: LAPOINTE LARRY
IPC: A47C7/50
Filed: 2015-08-27
Abstract: The present invention is in the form of a furniture member and includes a frame, a motor, a slide member, first and second bars, an axle, and first and second leg members. The furniture member of the present type is configured to overcome the problem of providing multiple chair positions or range of motion that maximize occupant choice of seating. The frame of the furniture member includes a chair portion movable relative to a base among nominal, reclined and lift positions. The slide member is connected to the motor and displaceable relative to the base. The first bar is connected to the slide member and the chair portion. The first bar moves the chair portion among the nominal, reclined and lift positions. The axle is mounted to the base portion. The leg members are attached to the axle and include fore and aft feet. The second bar is connected to the chair portion and slidably connected to the axle. The second bar rotates the axle in a first direction in response to movement into the reclined position and rotates the axle in a second direction in response to movement into the lift position.
Patent NZ-732667-A (NZ)
Title: A Bacteroides thetaiotaomicron strain and its use in reducing inflammation
Inventor: PATTERSON ANGELA MARGARET
IPC: A61K35/74
Filed: 2015-12-22
Abstract: The present invention provides a strain of Bacteroides thetaiotaomicron and derivatives thereof, and the use of said strain or derivatives in treating inflammatory, autoimmune and allergic disorders. The present invention further provides a Bacteroides thetaiotaomicron deposited as Accession Number 42341 at NCIMB. The invention also provides pharmaceutical compositions, nutritional supplements, feedstuffs, food products, dietary supplements, and food additives comprising said strain or derivatives.
Patent NZ-743481-A (NZ)
Title: Threshold Drain System and Method
Inventor: CASEY PAUL JAMES
IPC: E03F5/00
Filed: 2017-06-20
Abstract: A method of forming a threshold drain 31 is disclosed. The drain 31 extends alongside an exterior wall 4 of a building and is formed in an exterior surface 36. The building has an interior floor 21 with the exterior surface 36 and the interior floor 21 being substantially flush to permit traymobile, wheelchair and invalid access. In a single concrete pour, the drain gutter 31, exterior surface 36, interior floor 21 and a gutter 40 are all formed. The gutter has an exterior side wall 39 which supports a plurality of triangular cantilever arms 43. A support frame 42 having 2 longitudinally extending rims 51,52 is supported by the arms 43 and releasably receives a grate 32 between the rims 51, 52. The inner rim 51 is spaced from the wall 24 of the building, preferably by 10-12 mm, so as to provide a barrier to moisture in accordance with the Building Code of New Zealand standard set out in Clause E2 External Moisture. The drain 31 is also disclosed. Hitherto the construction of the threshold drain has required two concrete pours. The first pour forms the drain trench or gutter. Thereafter the support frame for the grate of the drain is installed on the poured concrete. Next a second concrete pour takes place so as to cover the supporting arms of the support frame and build up the exterior concrete surface to the level of the interior floor (less any provision for subsequent pavers to be laid on the exterior concrete surface). The present invention overcomes the need for two concrete pours which must, of necessity, take place on different dates to enable the first pour to set.